Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 June 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 205 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 5 results:
Author Title [ Type(Asc)] Year
Filters: Author is Stevens, R.  [Clear All Filters]
Journal Article
B. Feakins, Oke, J., McFadden, E., Aronson, J., Lasserson, D., O'Callaghan, C., Taylor, C., Hill, N., Stevens, R., and Perera, R., Trends in kidney function testing in UK primary care since the introduction of the quality and outcomes framework: a retrospective cohort study using CPRD, BMJ Open, vol. 9, p. e028062, 2019.
A. Farley, Koshiaris, C., Oke, J., Ryan, R., Szatkowski, L., Stevens, R., and Aveyard, P., Physician Support of Smoking Cessation After Diagnosis of Lung, Bladder, or Upper Aerodigestive Tract Cancer, Ann Fam Med, vol. 15, pp. 443-450, 2017.
R. Perera, McFadden, E., McLellan, J., Lung, T., Clarke, P., Perez, T., Fanshawe, T., Dalton, A., Farmer, A., Glasziou, P., Takahashi, O., Stevens, J., Irwig, L., Hirst, J., Stevens, S., Leslie, A., Ohde, S., Deshpande, G., Urayama, K., Shine, B., and Stevens, R., Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling, Health Technol Assess, vol. 19, pp. 1-401, vii-viii, 2015.
E. McFadden, Stevens, R., Glasziou, P., and Perera, R., Implications of lower risk thresholds for statin treatment in primary prevention: analysis of CPRD and simulation modelling of annual cholesterol monitoring, Prev Med, vol. 70, pp. 14-6, 2015.
J. P. Sheppard, Stevens, S., Stevens, R., Martin, U., Mant, J., Hobbs, F. D. R., and McManus, R. J., Benefits and Harms of Antihypertensive Treatment in Low-Risk Patients With Mild Hypertension, JAMA Intern Med, vol. 178, pp. 1626-1634, 2018.
[Page last reviewed 5 June 2020]